Shuttle Pharmaceuticals Holdings (SHPH) Change in Accured Expenses (2021 - 2026)

Shuttle Pharmaceuticals Holdings' Change in Accured Expenses history runs 6 years deep, the most recent figure standing at $335951.0 for Q1 2026.

• On a quarterly basis, Change in Accured Expenses rose 322.49% year-over-year to $335951.0 in Q1 2026; TTM through Mar 2026 was $679428.0, a 2075.0% increase from a year earlier, with the FY2025 full-year figure at $422994.0, up 2909.47% from the prior year.
• Change in Accured Expenses improved to $335951.0 in Q1 2026 per SHPH's latest filing, from -$453303.0 in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $1.0 million in Q3 2024 and bottomed at -$1.1 million in Q4 2024.
• The 5-year median for Change in Accured Expenses is $9592.0 (2022), against an average of $27733.0.
• Biggest YoY gain for Change in Accured Expenses was 8627.57% in 2024; the steepest drop was 2389.59% in 2024.
• Year by year, Change in Accured Expenses stood at $9592.0 in 2022, then jumped by 392.06% to $47198.0 in 2023, then sank by 2389.59% to -$1.1 million in 2024, then jumped by 58.05% to -$453303.0 in 2025, then jumped by 174.11% to $335951.0 in 2026.
• Per Business Quant, the three latest SHPH Change in Accured Expenses figures stand at $335951.0 (Q1 2026), -$453303.0 (Q4 2025), and $331198.0 (Q3 2025).